Benjamin Landry
Known title: General CounselCIK: 0001975281
Associated companies
Transaction History
| HCAT | ▼ Sell | Tax Withholding | 13,167 | $22K | 9/1/2026 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 13,779 | $19K | 6/1/2026 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 20,838 | $35K | 3/2/2026 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 6,317 | $11K | 2/26/2026 | View on chart |
| HCAT | ▲ Buy | Grant | 289,000 | $0 | 2/25/2026 | View on chart |
| HCAT | ▲ Buy | Grant | 16,473 | $0 | 2/25/2026 | View on chart |
| HCAT | ▼ Sell | Open Market | 27,425 | $72K | 12/5/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 14,387 | $42K | 12/1/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 6,175 | $21K | 9/5/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 3,138 | $11K | 9/2/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 6,057 | $24K | 6/5/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 3,255 | $12K | 6/2/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 13,827 | $63K | 3/6/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 9,024 | $41K | 3/3/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 97,500 | $0 | 2/20/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 13,538 | $0 | 2/20/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 2,500 | $19K | 1/6/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 19,268 | $160K | 12/6/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 9,419 | $85K | 12/1/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 2,466 | $18K | 9/6/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 1,222 | $9K | 9/3/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 2,387 | $16K | 6/6/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 1,300 | $8K | 6/3/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 12,577 | $83K | 5/31/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 3,315 | $27K | 3/1/2024 | View on chart |
| HCAT | ▲ Buy | Grant | 4,444 | $0 | 2/20/2024 | View on chart |
| HCAT | ▲ Buy | Grant | 75,000 | $0 | 2/20/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 3,427 | $26K | 12/1/2023 | View on chart |
| HCAT | ▲ Buy | Grant | 20,000 | $0 | 10/5/2023 | View on chart |
| HCAT | ▼ Sell | Open Market | 1,157 | $13K | 9/6/2023 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 500 | $6K | 9/1/2023 | View on chart |
| HCAT | ▼ Sell | Open Market | 1,179 | $13K | 7/7/2023 | View on chart |
| HCAT | ▼ Sell | Open Market | 1,078 | $13K | 6/6/2023 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 577 | $6K | 6/1/2023 | View on chart |
| HCAT | ▲ Buy | Grant | 20,000 | $0 | 5/3/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Health Catalyst Included in List of Unprofitable Stocks
Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.
Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.